A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies
Zhejiang University
Zhejiang University
Northwestern University
Case Comprehensive Cancer Center
Mayo Clinic
National Institutes of Health Clinical Center (CC)
University of Kansas Medical Center
University of Kansas Medical Center
Case Comprehensive Cancer Center
National Cancer Institute (NCI)